Clinical Trials Logo

Clinical Trial Summary

A phase 1 clinical trial to evaluate safety, PK/PD profiles and food effects of URC102 in patients with renal impairment and healthy people.

Clinical Trial Description

This trial will evaluate 1. in patients with renal impairment: the safety, pharmacokinetics and pharmacodynamics after single oral administration of URC102 under fasted conditions. 2. in healthy adult subjects: the safety, pharmacokinetics and pharmacodynamics of 2 single doses of URC102 in the morning after fasting or after a high-fat breakfast. The 2 doses will be separated by a washout period. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05198778
Study type Interventional
Source JW Pharmaceutical
Status Completed
Phase Phase 1
Start date November 29, 2021
Completion date July 13, 2022